MIRA INFORM REPORT
|
Report Date : |
10.04.2008 |
IDENTIFICATION
DETAILS
|
Name : |
JOHNSON AND JOHNSON LIMITED |
|
|
|
|
Registered Office : |
Spencer’s Building, 30, Forjett Street, Mumbai – 400 036, Maharashtra,
India |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
05.09.1957 |
|
|
|
|
Com. Reg. No.: |
11-10928 |
|
|
|
|
CIN No.: [Company Identification No.] |
U33110MH1957PTC010928 |
|
|
|
|
TAN No.: [Tax Deduction & Collection Account No.] |
MUMJ05781G |
|
|
|
|
Legal Form : |
A closely held Public Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacturing and Selling of various Healthcare products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
Maximum Credit Limit : |
USD 9000000 |
|
|
|
|
Status : |
Excellent |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well – established and reputed company having fine track.
Available information indicates high financial responsibility of the company.
General financial position is good. Fundamentals are strong and healthy.
Payments are reported as usually correct and as per commitments. The company can be considered good for any normal business dealings. It can be regarded as a promising business partner in a medium to long
run. |
LOCATIONS
|
Registered Office : |
Spencer’s Building, 30, Forjett Street, Mumbai – 400 036, Maharashtra,
India |
|
Tel. No.: |
91-22-23861431 / 24241431/23861451 / 6664
6464 |
|
Fax No.: |
91-22-23871482 / 23801482 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factory : |
Consumer Products Division, Lal Bahadur
Shastri Marg, Mulund (West), Mumbai – 400 080, Maharashtra, India |
|
|
|
|
Overseas Offices : |
Located at: Canada, Argentina, Brazil, Chile, Colombia, Mexico, Panama, Peru,
Puerto Rico, Uruguay, Vruezuela, Austria, Belgium, Czech Republic, Denmark,
England, Finland, France, Germany, Greece, Hungary, Ireland, Italy, The
Netherlands, Norway, Poland, Portugal, Russia, Scotland, Slovenia, Spain,
Sweden, Switzerland, Turkey, Australia, China, Egypt, Hong Kong, Indonesia,
Israel, Japan, Korea, Malaysia, Morocco, Pakistan, Philippines, Saudi Arabia,
Singapore, South Africa, Taiwan, Thailand, United Arab Emirates, etc. |
|
|
|
|
Branches : |
Located at: - ·
Kolkata, West Bengal ·
Chennai, Tamilnadu ·
New Delhi |
DIRECTORS
|
Name : |
Mr. Shantaram Yeshwant Rege |
|
Designation : |
Director |
|
Address : |
Moonreach Apartment, Prabhadevi, Mumbai – 400 025, Maharashtra, India |
|
Date of Birth/Age : |
02.05.1927 |
|
Date of Appointment : |
12.03.2004 |
|
Date of Ceasing: |
25.06.2005 |
|
|
|
|
Name : |
Mr. Manish Yadav |
|
Designation : |
Director |
|
Address : |
2N 1/2 N3, Samshiba , 1st Floor, Pali Hill, (Nargis Dutt
Road), Bandra (West), Mumbai – 400 050, Maharashtra, India |
|
Date of Birth/Age : |
29.03.1966 |
|
Date of Appointment : |
29.03.2006 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Narendra Kumar Ambwani |
|
Designation : |
Director |
|
Address : |
4, Shangri - La 27 – A, Carmicheal Road, Mumbai – 400 026,
Maharashtra, India |
|
Date of Birth/Age : |
15.11.1948 |
|
Date of Appointment : |
01.07.2005 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Vaidheesh Annaswamy |
|
Designation : |
Director |
|
Address : |
Flat No. N -1, 14th
Floor, Eden Hall, Dr. A B Road, Worli , Mumbai – 400 018, Maharashtra, India |
|
Date of Birth/Age : |
16.09.1959 |
|
Date of Appointment : |
12.03.2007 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Rajan Sunderdas Tejua |
|
Designation : |
Director |
|
Address : |
29 Mooncraft Apartments, Sherly Rajan Road, Off Carter Road, Bandra
(West), , Mumbai – 400 050, Maharashtra, India |
|
Date of Birth/Age : |
17.09.1960 |
|
Date of Appointment : |
14.12.2006 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Marco Philipus Ardeshir Wadia |
|
Designation : |
Director |
|
Address : |
Thakur Nivas 173, Jamshedji Tata Road , Mumbai – 400 020, Maharashtra,
India |
|
Date of Birth/Age : |
30.01.1956 |
|
Date of Appointment : |
28.11.2003 |
|
Email: |
|
|
|
|
|
Name : |
Mr. Suresh Talwar |
|
Designation : |
Director |
|
Address : |
Shiv Shanti Bhuvan, M Karve Road, Churchgater, Mumbai – 400 006,
Maharashtra, India |
|
Date of Birth/Age : |
21.11.1937 |
|
Date of Appointment : |
06.06.2001 |
|
Date of Ceasing: |
13.04.2005 |
|
|
|
|
Name : |
Mr. Rajesh Dalal |
|
Designation : |
President & Executive Director |
|
Address : |
La Kozy Mansion 212 Chowpatty, Mumbai – 400 007, Maharashtra, India |
|
Date of Birth/Age : |
12.09.1953 / 25 years |
|
Qualification : |
B. Tech (Mechanical), M. M. S. |
|
Experience : |
25 years |
|
Date of Appointment : |
05.05.2000 |
|
Date of Ceasing: |
18.03.2005 |
|
Previous
Employment: |
Garware Paints Limited - Assistant to
Marketing Manager |
|
|
|
|
Name : |
Mr. N. K. Ambwani |
|
Designation : |
President and Managing Director |
|
Age: |
54 years |
|
Qualification: |
B. Tech. (Electronics), P.G.D.B.A. |
|
Experience: |
30 years |
|
Date of Joining: |
01.05.1995 |
|
Previous
Employment: |
Johnson & Johnson Limited, Indonesia –
Managing Director |
|
|
|
|
Name |
Mr. P. Chakraborty |
|
Designation |
Vice President – Cordis |
|
Age |
40 years |
|
Qualification |
B.E., P.G.D.M. |
|
Experience |
18 years |
|
Date of Joining |
02.12.1991 |
|
Previous
Employment |
Otis Elevator Company [India] Limited –
Assistant Sales Manager |
|
|
|
|
Name : |
Mr. Samir Kochhar |
|
Designation : |
Project Director – Reg. Logistics |
|
Age |
39 years |
|
Qualification |
B.E., M.B.A. |
|
Experience |
13 years |
|
Date of Joining |
14.02.2001 |
|
Previous
Employment |
G. E. Industrial Systems – Vice President
Operations |
|
|
|
|
Name : |
Mr. H. B. Joshipura |
|
Designation : |
President & Executive Director |
|
Age |
45 years |
|
Qualification |
B. E., M.B.A. |
|
Experience |
20 years |
|
Date of Joining |
27.09.2001 |
|
Previous
Employment |
Hindustan Lever Limited – Head Consumer
Services |
|
|
|
|
Name : |
Dr. A. S. Manke |
|
Designation : |
Director , Woundcare Reg. Development |
|
Age |
48 years |
|
Qualification |
M.Sc.[Tech.], D. Phil |
|
Experience |
19 years |
|
Date of Joining |
01.02.1990 |
|
Previous
Employment |
Shalimar Paints Limited, Manager –
Research & Development |
|
|
|
|
Name : |
Mr. T. M. Venkatesan |
|
Designation : |
Director – Strategic Sourcing |
|
|
|
|
Name |
Mr. T. P. Mehta |
|
Designation |
Vice President – Ethicon |
|
Age |
50 years |
|
Qualification |
B.Sc., M.M.M. B.D.M.A. |
|
Experience |
28 years |
|
Date of Joining |
17.03.1975 |
|
Previous
Employment |
SPAM – Acting Representative |
|
|
|
|
Name |
Mr. S. G. Raote |
|
Designation |
Vice President – Customer Development
& Exports |
|
Age |
38 years |
|
Qualification |
B. Pharm, P.G.D.M., D.C.P. |
|
Experience |
14 years |
|
Date of Joining |
15.02.1991 |
|
Previous
Employment |
J. L. Morision [India] Limited – Product
Manager |
|
|
|
|
Name |
Mr. B. B. Shah |
|
Designation |
General Manager – Finance |
|
Age |
34 years |
|
Qualification |
B. Com, I.C.W.A., A.C.A., C.F.A. |
|
Experience |
13 years |
|
Date of Joining |
01.10.1996 |
|
Previous
Employment |
Nocil Mafatlal Centre – Finance Officer |
|
|
|
|
Name |
Mr. A. K. Singhal |
|
Designation |
Reg. Director Customer Development |
|
Age |
45 years |
|
Qualification |
B.E., P.G.D.M. |
|
Experience |
20 years |
|
Date of Joining |
03.10.1989 |
|
Previous
Employment |
Lipton India Limited – Product Manager |
|
|
|
|
Name |
Mr. R. A. Vaidya |
|
Designation |
Reg. Product Development Director |
|
Age |
51 years |
|
Qualification |
B.E. [Mech.] |
|
Experience |
27 years |
|
Date of Joining |
11.04.1986 |
|
Previous
Employment |
Union Carbide – Maintenance Engineer |
|
|
|
|
Name |
Mr. T. M. Venkatesan |
|
Designation |
Director – Strategic Sourcing |
|
Age |
54 years |
|
Qualification |
S.S.C. |
|
Experience |
36 years |
|
Date of Joining |
12.02.1971 |
|
Previous
Employment |
The Oswal Pen Company – Sales
Representative |
KEY EXECUTIVES
|
Name : |
Mr. Anil Vasantrai Upadhyay |
|
Designation : |
Secretary |
|
Address : |
81 – A, Twin Towers, Off Veer Savarkar Marg, Prabhadevi , Mumbai – 400
025, Maharashtra, India |
|
Date of Birth/Age : |
22.09.1958 |
|
Date of Appointment : |
01.09.2000 |
|
Email: |
|
|
|
|
|
Name : |
Mr. T. P. Mehta |
|
Designation : |
Vice President – Ethicon |
|
|
|
|
Name : |
Mr. P. Chakraborty |
|
Designation : |
Vice President – Cordis |
|
|
|
|
Name : |
Mr. S. G. Raote |
|
Designation : |
Vice President – Customer Development & Exports |
|
|
|
|
Name : |
Mr. B. B. Shah |
|
Designation : |
General Manager – Finance |
|
|
|
|
Name : |
Mr. A. K. Singhal |
|
Designation : |
Reg. Director Customer Development |
|
|
|
|
Name : |
Mr. R. S. Tejuja |
|
Designation : |
Vice President – JJM |
|
|
|
|
Name : |
Mr. A. Vaidheesh |
|
Designation : |
Executive Vice President Endo Sur |
|
|
|
|
Name : |
Mr. R. A. Vaidya |
|
Designation : |
Reg. Product Development Director |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders (as on 31.03.2007):- |
|
No. of Shares |
|
M/s Johnson and Johnson |
|
1080000 |
|
M/s Depuy Medical Private limited |
|
360000 |
|
|
Total
|
1440000 |
Equity Shares Breakup (Percentage of Total Equity): (as on 31.03.2007)
|
Sr No. |
Category |
Percentage |
|
1 |
Foreign holdings (Foreign institutional investors ) foreign companies
foreign financial institutions , non residents or Overseas corporate bodies
or others |
75.00 |
|
2 |
Bodies Corporate |
25.00 |
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturing and Selling of various Healthcare products. |
||||||||||||||||
|
|
|
||||||||||||||||
|
Products : |
|
GENERAL
INFORMATION
|
No. of Employees : |
108300 |
|
|
|
|
Bankers : |
The Hong Kong and the Shanghai Banking
Corporation Limited Address: 52/60, Mahatma Gandhi Road, Fort, Mumbai – 400 001,
Maharashtra, India |
|
|
|
|
Banking
Relations : |
Good |
|
|
|
|
Auditors : |
|
|
Name : |
Lovelock & Lewes Chartered Accountants |
|
Address: |
1252 Veer Savarkar Marg, Shivaji Park, Dadar , Mumbai – 400 028,
Maharashtra, India |
|
|
|
|
Holding Company : |
Johnson and Johnson, USA |
|
|
|
|
Associates/Subsidiaries : |
Associates: ·
Advanced Sterilization Products, USA ·
Biosense Webster Inc, U.S.A. ·
Cilag Ag International ·
Codman Sarl, Switzerland ·
Cordis Corporation ·
Cordis Europa N.V. ·
Cordis Europa N.V. Netherlands ·
Cordis, Hong Kong ·
Depuy International Limited ·
Depuy Orthopadie GmbH ·
Ethicon Endo Surgery Inc. ·
Ethicon GmbH ·
Ethicon Inc., U.S.A. ·
Ethicon Limited, U.K. ·
Ethicon Sarl, Switzerland ·
J and J [Hong Kong] Limited ·
J and J [Middle East] Inc ·
J and J Health Care Systems
Inc., U.S.A. ·
J and J Limited, England ·
J and J Medical [Shanghai]
Limited ·
J and J Medical Philippines ·
J and J Medical Taiwan ·
J and J Personal Products WW ·
J and J Taiwan Limited ·
J and J Sdn Bhd, Malaysia ·
J and J [Thailand] ·
Jannsen Pharmaceutica Limited, Phillipines ·
Janssen Pharmaceutica Limited, Bangkok ·
Janssen Pharmaceutica, Belgium ·
Johnson and Johnson [Hong Kong
] Limited ·
Johnson and Johnson Asia
Pacific ·
Johnson and Johnson China
Limited ·
Johnson and Johnson Consumer
France ·
Johnson and Johnson Consumer
Products Company ·
Johnson and Johnson Consumer
Shared Services ·
Johnson and Johnson France ·
Johnson and Johnson GmbH,
Germany ·
Johnson and Johnson K. K.
Japan ·
Johnson and Johnson Medical
Belgium ·
Johnson and Johnson Medical
Indonesia ·
Johnson and Johnson Medical
Korea ·
Johnson and Johnson Medical
Malaysia ·
Johnson and Johnson Medical
Pty Limited ·
Johnson and Johnson Medical
Pty Limited, Australia ·
Johnson and Johnson Medical
Singapore ·
Johnson and Johnson Medical
U.K. ·
Johnson and Johnson Medical,
Texas ·
Johnson and Johnson Pacific
Pty Limited ·
Johnson and Johnson
Philippines ·
Johnson and Johnson Pte.
Limited ·
Johnson and Johnson Sales
and Logistic Company ·
Johnson and Johnson Thailand
Limited ·
Johnson and Johnson USA ·
Johnson and Johnson Vision
Prod. Inc. ·
Johnson and Johnson Consumer
Products WW ·
Johnson and Johnson
Professional Exports ·
Johnson Regional Services, Asia Pacific ·
Lifescan Inc., U.S.A. ·
Networking and Computing
Services ·
NR Jet Enterprises Limited ·
Olympus Enterprises Limited ·
Ortho Clinical Diagnostics Australia ·
Ortho Clinical Diagnostics Belgium ·
Ortho Clinical Diagnostics England ·
Ortho Clinical Diagnostics European Supp Ctr. ·
Ortho Clinical Diagnostics France ·
Ortho Clinical Diagnostics Singapore ·
Ortho Diagnostics Systems Inc., USA ·
Ortho Diagnostics Systems, Spain ·
Ortho Mcniel Pharmaceutical Corporation ·
Pharmaceutical Sourcing Group America ·
Sales and Logistics Co. USA ·
DePuy Medical Private limited Subsidiaries: ·
Johnson and Johnson Exports
(India) Limited ·
Suryalay Investments and
Trading Company Limited (U65990MH1981PTC023690) ·
Deshraj Investment and Trading
Company Limited (U65990MH1981PLC023828) ·
Sabarmati Builders and
Investments Limited ·
Loyalty Investments and
Enterprises Limited (U67120MH1984PTC032582) ·
Key to Riches Investment and
Leasing Limited (U67120MH1987PTC043329) |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1500000 |
Equity Shares |
Rs. 100/- each |
Rs.150.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1440000 |
Equity Shares |
Rs. 100/- each |
Rs.144.000
millions |
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.12.2006 |
31.12.2005 |
31.12.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
144.000 |
144.000 |
144.000 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
2205.994 |
1171.418 |
968.300 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
2349.994 |
1315.418 |
1112.300 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
2349.994 |
1315.418 |
1112.300 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1126.399 |
938.918 |
919.400 |
|
|
Capital work-in-progress |
703.773 |
204.606 |
57.300 |
|
|
|
|
|
|
|
|
INVESTMENT |
103.414 |
1.688 |
0.100 |
|
|
DEFERREX TAX ASSETS |
336.059 |
287.046 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
1294.190
|
1191.241 |
1015.700 |
|
|
Sundry Debtors |
651.857
|
591.803 |
590.900 |
|
|
Cash & Bank Balances |
1655.809
|
2117.592 |
1473.600 |
|
|
Other Current Assets |
2.805
|
1.909 |
0.000 |
|
|
Loans & Advances |
2005.812
|
1354.515 |
1525.200 |
|
Total
Current Assets |
5610.473
|
5257.060 |
4605.400 |
|
|
Less : CURRENT LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
4385.491
|
3853.616 |
2817.600 |
|
|
Provisions |
1144.633
|
1520.284 |
1652.300 |
|
Total
Current Liabilities |
5530.124
|
5373.900 |
4469.900 |
|
|
Net Current Assets |
80.349
|
[116.840] |
135.500 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
2349.994 |
1315.418 |
1112.300 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
|
31.12.2005 |
31.12.2004 |
|
|
Sales Turnover |
|
14051.500 |
11890.700 |
|
|
Other Income |
|
864.900 |
655.200 |
|
|
Total Income |
|
14916.400 |
12545.900 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
|
1989.800 |
1718.900 |
|
|
Provision for Taxation |
|
807.700 |
660.600 |
|
|
Profit/(Loss) After Tax |
|
1182.100 |
1058.300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Manufacturing Expenses |
|
439.800 |
414.700 |
|
|
Administrative Expenses |
|
3306.800 |
2717.000 |
|
|
Raw Material Consumed |
|
6173.900 |
4981.500 |
|
|
Excise Duty |
|
748.600 |
803.300 |
|
|
Salaries, Wages, Bonus, etc. |
|
1456.200 |
1221.800 |
|
|
Interest |
|
1.000 |
0.100 |
|
|
Power & Fuel |
|
63.800 |
61.200 |
|
|
Depreciation & Amortization |
|
204.300 |
220.300 |
|
|
Other Expenditure |
|
696.400 |
460.500 |
|
Total Expenditure |
|
13090.800 |
10880.400 |
|
KEY RATIOS
|
PARTICULARS |
|
31.12.2006 |
31.12.2005 |
31.12.2004 |
|
PAT / Total
Income |
(%) |
NA
|
7.92 |
8.43 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
NA
|
14.16 |
14.45 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
NA
|
29.74 |
30.79 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
NA
|
1.51 |
1.55 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.35
|
4.09 |
4.19 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.01
|
0.97 |
1.03 |
LOCAL AGENCY
FURTHER INFORMATION
FORM 8:-
|
Name of the company |
JOHNSON AND
JOHNSON LIMITED |
|
Presented By |
The Hong Kong and Shanghai Banking Corporation Limited (Hong Kong Bank 52/60 , Mahatma Gandhi Road, Mumbai – 400 001,
Maharashtra, India) |
|
1) Date and description of instrument creating the change |
Deed of hypothecation dated 05.02.1999 |
|
2) Amount secured by the charge/amount owing on the securities of
charge |
Rs. 100.000 millions |
|
3) Short particular of the property charged. If the property acquired
is subject to charge, date of the acquired of the property should be given |
As per the Scheduled attached |
|
4) Gist of the terms and conditions and extent and operation of the
charge. |
In consideration of the Bank subscribed /
agreed to subscribe to the non- convertibles secured Debentures of the
company, the company has hypothecated and charged to the bank by way of first
charge as a continuing security , the assets mentioned in item No. 3 above to
secure the repayment of the advances together with Interest cost and all
other charges. Interest at the rate on 13.00% per annum shall be payable by
the company, subject however that the bank shall have the right to change the
rate of Interest after giving notice to the company. The company shall
maintain such margin of security as may be specified by the bank form time to
time. in case the company fails to fulfill its obligations under the agreement
, the bank shall be entitled to take possession of the hypothecation
properties and sell them by public auction or private contract and utilize
the proceeds in full or part settlements of its claims. |
|
5) Name and Address and description of the person entitled to the
charge. |
The Hong Kong and the Shanghai Banking
Corporation Limited Address: 52/60, Mahatma Gandhi Road, Fort,
Mumbai – 400 001, Maharashtra, India |
|
6) Date and brief description
of instrument modifying the charge |
NA |
|
7) Particulars of modifications specifying the terms and conditions or
the extent of operations of the charge in which modification is made and the
details of the modification. |
NA |
|
The Schedule
referred to above The whole of the movable properties of the borrower including its
movable plant and machinery , machinery spares, tools and accessories and
other movables , both present and future whether installed or not and whether
now lying loose or in case or which are now lying or stored in or about or
shall hereafter from time to time
during the continuance of the security of the charge by way of hypothecation
be brought into or upon or be stored or be in or about the borrower factories
premises and godown or wherever else
the same may be or be held by any party to the order or disposition of the
borrower or in the course of transit or on high possession of the
borrower and either by way of
substitution or addition and all documents of title, negotiable instrument,
policies of Insurance and other documents and / or instruments relating
thereto. |
|
WEBSITE DETAILS:
History
Subject spread its roots
to the world’s largest democracy, India, during the endemic post-independence
turmoil of 1947. It was Mr. Patrick Whaley who set about with confidence and
determination during this period of turbulence to begin the wok of establishing
the company in the subcontinent. Things progressed quickly and by 1948,
Johnson’s Baby Powder was being
manufactured by British Drug House in Prabhadevi, Bombay, and marketed by the
company.
Other consumer products like TEK toothbrushes, Johnson’s Baby Cream and Prickly
Heat Powder followed suit. However, highly specialized products like
Belladonna plasters, pharmaceuticals and Permacel Tapes were imported from the
parent company. It was only ten years later that the company began to
manufacture its own products.
In September 1957, a new company, Johnson and Johnson India Limited was created
and registered with twelve employees on its rolls.
In the 50 years since its establishment as a modest 12-employee outfit, the
company has gained a reputation for delivering high-quality products at
competitive prices. Their success, they believe, stems from their staunch
commitment to caring for and catering to the needs of their customers and
employees.
The company is the most
comprehensive manufacturer of healthcare products, selling more than 100 different products in the consumer, pharmaceutical and professional
markets. Since 50 years of establishment in India, they have gained a
reputation for delivering high-quality
products at competitive prices. Their success stems from their staunch commitment to caring for and catering
to the needs of their customers and employees.
Their quest to provide high-quality,
yet cost-effective products has led to active R and D efforts. Rich dividends have led not only to innovations in the pharmaceutical industry,
surgical science and diagnostics industry, but has also earned them an
important place in virtually every household. Their success has also helped
them introduce and continuously
innovate on highly sophisticated products for new markets in India.
Johnson and Johnson Consumer
Products Division is one of the leading
fast moving consumer goods manufacturer in India. It is also among the most consistent and successful enterprises not
just in the J and J world-wide group of companies, but also in India. Johnson
and Johnson Consumer Products division has been growing steadily over the last few years, and is one of the few
companies in the Indian market to grow at extremely healthy levels.
The Consumer Products Division owes its success to the strength of its brands, and the loyalty they enjoy from consumers, a strong sense of values driven from the Credo, and an
environment, which sets the toughest
standards of leadership.
Marketing
The consumer division in India has 5 major franchises namely - Baby, Wound Care, Women's Health, Skin Care and Adult Toiletries. Johnson's Baby is the leading brand of the company in India,
and is recognized the world over by mothers, and healthcare professionals as
the trusted name in baby care. Johnson's Baby products are the mildest and safest products for use on
babies.
Band-Aid is the well-known brand of Adhesive Bandages from the stable of the company in the Wound Care
portfolio. Band-Aid enjoys the market
leadership in this category, and is internationally known as an innovative brand. Together with Savlon, they comprise the Wound Care
Franchise. Stayfree, a brand of
sanitary napkins from the company is also the market leader in the Sanitary Napkins category with its varied
assortment of napkins suited for every need.
CDO
At the company, customer focus is an all-permeating philosophy. Their
Sales department is called Customer Development, which signifies the purpose
and goal of the function as not just selling but also Customer development.
This is in keeping with their commitment to their customers as stated in Their
Credo.
Their Customer Development organization is organized geographically and
includes both Domestic Sales within India and Exports to neighboring countries.
Given below are some of their initiatives towards customer development:
·
Customer
Service and Support Group (CSSG)
·
Academy for
Excellence in Customer Development
Consumer
(Operations)
Johnson and Johnson Consumer Products India
(JJCPI) Operations is a part of the Asia Pacific Regional Operations. It
markets its products not only within India but also to other Affiliate and
Non-Affiliate countries including U.S.A, which houses the Company Headquarters.
The One Team One Aim work
culture nurtures individual passion that drives collective achievement, which
has led to excellence and achievement in a competitive environment. Employees
have the absolute freedom to express
themselves, work intelligently and
contribute within the framework of the Company Credo. While the job is no doubt demanding, rewarding remuneration and the friendly work atmosphere more than
make up for the efforts put in.
Continuous improvement is of
utmost importance at JJCPI Operations. Training in the most recent management tools is imparted to the team to assist
them in achieving world class quality services and products. Emphasis is also
laid on Process Improvement by
using Process Excellence tools viz. Six
Sigma and Lean. The health and safety of the employees and environment
protection is of prime concern in the Operations division. JJCPI Operations has
a certified ISO 140001 manufacturing
plant at Mulund among the many laurels to its credit in the field of safe
working. The numerous National and
Inter-National Awards adorning the plant bear witness to its many achievements
in this important area. Also, in its pursuit for continuous Quality Improvement and Cost Reduction, the
division has adopted new technologies, which are environment friendly.
JJCPI Operations as a whole, is customer driven by a inner passion and zeal to
meet customer requirements at the highest service level.
Consumer
(R
and D and QA)
Johnson and Johnson Technical Laboratory is
recognized by the Department of Science and Technology, New Delhi. The
technical organisation comprises of a team of dedicated and qualified
scientists aiming to create total consumer offerings with specific focus on
products, packages and advertising claims by working in partnership with
Marketing and Product Supply organizations.
The vision of the technical team is to continuously meet the consumer
health care needs, building lifelong bonds, partnering with customers and
health care professionals.
The innovative organization is fun to work in and passionately practices
the Standards of Leadership and effective leadership standards.
J and J Consumer Lab with its pool of outstanding talent is considered
to be the 'best in class' in the AsPac region. The team not only caters to the
needs of the local consumer, but also leads the development of concept /
product / packages for the overseas market.
To this end, several new products have been successfully developed and
launched by understanding consumer requirements thereby uncovering their
unarticulated needs. Some of the new products launched in recent years in the
local Indian market are:
·
Johnson's Baby Milk Bath
·
Johnson's Baby Oil with Vitamin D
·
Savlon Soap
·
Johnson's Baby Moisturising Soap (Regular and Blossoms)
The increased focus of the technical team is
to churn out more and more new products and processes with enhanced speed to
market in order to keep up the customers' delight.
PRODUCT PORTFOLIO
The company is the world's most comprehensive and broadly-based
manufacturer of health care products as well as a provider of related services
for the consumer. Thousands of products across a wide range of categories are
constantly innovated, manufactured and marketed to help families all over the
world lead healthy, happy lives.
·
Johnson Baby
·
Johnson's Baby Milk Soap (For Broadband connection)
·
Johnson's Baby Milk Soap (For Dialup connection)
·
Johnson's Baby Shampoo (For Broadband connection)
·
Johnson's Baby Shampoo (For Dialup connection)
Health Care
Janssen-Cilag is a leading research-based pharmaceutical company,
with more than 19,000 employees world-wide and establishments in about 50
countries around the world..
In India, Janssen-Cilag markets prescription and over-the-counter medicines for
a range of conditions in the areas of gastroenterology, fungal infections,
women's health, oncology, nephrology, mental health, neurology, pain relief,
etc. There is also a stability centre that does extensive work for
International affiliates of the company.
Medical
Johnson and Johnson Medical India (JJMI), a division of the company is
one of the largest and most
comprehensive Medical Devices Company in India. The rise of this
division has been through the consistent
delivery of innovative, high quality, and cost effective products and
services that has enhanced clinical outcomes and improved the quality of healthcare.
JJMI encompasses well-known franchises in India. Among them are Ethicon,
the world leader in surgical sutures,
Cordis, the
crowning glory in the cardiology
segment, Johnson and Johnson Hospital Services (JJHS), a predominant player in the
infection prevention market and DePuy, among the
fore - runners in the Orthopaedics
market.
Ortho Clinical
Diagnostics:-
Ortho-Clinical Diagnostics(OCD) is part of the company and is a leading provider of high-value diagnostic
products and services to the global health care community.
For more than half a century, OCD has been providing accurate, timely and
cost–effective solutions for screening,
diagnosing, monitoring and confirming diseases. OCD is present in
India for the last 25 years as an independently managed division of Johnson and
Johnson. This team is responsible for marketing its products to neighboring
Bangladesh, Nepal, Sri Lanka and Maldives.
Vision Care
Headquartered in Jacksonville, Florida, Vistakon is a division of
Johnson and Johnson Vision Care, Inc. A true
leader in innovation, Vistakon revolutionized
the vision correction industry in 1988 with the invention of ACUVUE® Brand Contact Lenses, the
world's first soft disposable contact lens.
Today, it is the number one brand in
the world, worn by more people globally than any other contact lens.
Through constant innovation, an outstanding range of contact lens options is
available to the people according to their need. It has truly transformed the
world's vision through the freedom, comfort and clarity of natural vision.
Business Services
Group
The business services division at the
company consists of an umbrella of services including Finance, Human Resources, Information Management, Administration and
the Legal department.
Together, they facilitate the working of the operating divisions of the
company.
Career:
The company has always believed that its strength lies within the talent
it attracts and retains. The Credo espouses the responsibility of the company towards
its key constituent "employees". Managements all over the world and
in India strive to create a great work
environment to help employees reach their potential through Systematic Talent Management processes.
This 100-year-old company is
built on a rock solid unchangeable core ideology, the Credo, that drives every
aspect of how the company and manages its employees.
Whether it is through well-entrenched Performance
Management systems, culture building tools like the Credo Survey and Feedback Process, Global Standards of Leadership, 360 degree feedback, Formal Learning and Development processes or
Career Planning Processes, the attempt is always to develop leaders who can build a transparent, trusting, performance oriented
culture.
The philosophy of decentralization that the company is well known for across
the globe gives tremendous freedom at
work and early responsibilities to all Johnsonians. Entrepreneurial drive and a superior ability to work in an ever
complex, competitive and changing business environment along with uncompromising values, is what makes a
Johnsonian.
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The
Courts, India Prisons Service, Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.39.95 |
|
UK Pound |
1 |
Rs.78.91 |
|
Euro |
1 |
Rs.63.24 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
9 |
|
PAID-UP CAPITAL |
1~10 |
9 |
|
OPERATING SCALE |
1~10 |
9 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
10 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
9 |
|
--LEVERAGE |
1~10 |
9 |
|
--RESERVES |
1~10 |
9 |
|
--CREDIT LINES |
1~10 |
9 |
|
--MARGINS |
-5~5 |
---- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
YES |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
81 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market
trend (10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|